

NTR benefits from strong potash and nitrogen demand, higher fertilizer prices and cost gains, while sulfur costs and volume constraints weigh on results.

As of Sept. 1, 2026, three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

On CNBC's “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, said Goldman Sachs Nasdaq-100 Premium Income ETF (NASDAQ:GPIQ) has a 10.5% yield.

Nutrien is lowered to a Hold after a mixed Q2, as higher sales were accompanied by weaker profitability, lower fertilizer volumes, and higher sulfur costs. Long-term fertilizer demand remains tied to crop production, but that does not remove the cyclicality of Nutrien's earnings. Near-term uncertainty remains in nitrogen, phosphate, and Retail, while potash performed better and the lower end of 2026 potash volume guidance was raised.

BlackRock Inc. acquired a new position in shares of Nutrien Ltd. (NYSE: NTR) during the undefined quarter, according to its most recent filing with the SEC. The institutional investor acquired 3,509,808 shares of the company's stock, valued at approximately $220,942,000. BlackRock Inc. owned 0.73% of Nutrien at the end of the most recent

Bank of New York Mellon Corp bought a new position in shares of Nutrien Ltd. (NYSE: NTR) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,379,599 shares of the company's stock, valued at approximately $86,846,000. Bank of New

Wall Street is making bold moves Tuesday, upgrading AMD and shaking up fintech names like Klarna and Shift4 while fresh initiations hit Fortune Brands and Jersey Mike's. Find out which stocks analysts are backing and which they are walking away from.

Shares of Nutrien Ltd. (NYSE: NTR - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twenty-one brokerages that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and seventeen have given a buy recommendation to the company. The